FIELD: medicine. SUBSTANCE: method involves making contraception by means of preparation containing estrogen selected from 2.0-6.0-mg of 17β- estradiol and 0.015-0.02 mg of ethynyl estradion and gestagen selected from 0.05- 0.075 mg of Gestodene, 0.075-0.125 mg of Levonorgestrel, 0.06-0.15 mg of Desogestrel, 0.06-0.15 mg of 3-keto-desogestrel, 0.1-0.3 mg of Drospyrenon, 0.1-0.2 mg of Cyproterone acetate, 0.2-0.3 mg of Norgestimate and more than 0.35-0.75 mg of Noretisteron. The dosing form is administered during 23-24 days beginning from the first day of the menstrual cycle and following 4-5 days without taking pills or taking pills containing no drugs. The total administration cycle being is 28 days long. Individual dosage forms have constant amount of estrogen/gestagen the whole 23-24 days long. EFFECT: improved control of the cycle; low hormone doses. 16 cl, 2 dwg
